2BB score and signals
Ovid Therapeutics Inc.’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 14 | Very Low |
| Momentum | 26 | Weakening |
| Financial strength | 49 | Normal |
| Quality | 40 | Normal |
| Risk | 42 | Moderate |
Company facts
| Founded | 2014 |
| Employees | 23 |
| 52-week range | $0.55 – $3.10 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.1046 | — | $18,941.00 |
| 2026-08-18 | — | -0.1173 | — | $0.00 |
| 2026-05-12 | -0.12 | -0.1227 | $0.00 | $33,150.00 |
| 2026-03-18 | 0.06 | -0.1214 | $718,000.00 | $13,596.00 |
Related companies
2BBBullish & Bearish